It is well-known that a great majority of CRC patients carry mutations in the adenomatous polyposis coli (APC) or beta-catenin (CTNNB1) gene and that both genes are involved in the Wnt/beta-catenin signaling pathway [36–40]. The gene discussed is CTNNB1; the disease is colorectal carcinoma.